ANEMIA

PRERNA FOR IAS

ANEMIA

1. Anemia – Definition

Anemia is a condition in which the number of red blood cells (RBCs) or the level of hemoglobin (Hb) in the blood is lower than normal. Since hemoglobin carries oxygen from the lungs to body tissues, anemia reduces the blood’s oxygen-carrying capacity. As a result, the body receives less oxygen, causing symptoms such as fatigue, weakness, pale skin, dizziness, and shortness of breath. Anemia is not a disease itself but a sign of an underlying health problem. It may result from nutritional deficiencies, blood loss, bone marrow disorders, inherited conditions, or increased destruction of red blood cells.

2. Iron Deficiency Anemia

Iron Deficiency Anemia is the most common type of anemia worldwide and occurs due to insufficient iron, which is essential for hemoglobin synthesis. It produces microcytic, hypochromic red blood cells, meaning they are smaller and paler than normal. Common causes include poor dietary intake, chronic blood loss, pregnancy, and intestinal malabsorption. Symptoms include fatigue, weakness, pale skin, dizziness, brittle nails, and pica, a craving for non-food substances like clay or ice. Laboratory findings include low serum iron, low ferritin, increased total iron-binding capacity (TIBC), and reduced hemoglobin levels. Treatment involves iron supplementation and correcting the underlying cause.

3. Megaloblastic Anemia

Megaloblastic anemia develops due to a deficiency of Vitamin B₁₂ or folic acid, both of which are essential for DNA synthesis. The bone marrow produces unusually large, immature red blood cells called megaloblasts, resulting in macrocytic anemia. Patients experience fatigue, weakness, pale skin, and glossitis (inflamed tongue). Vitamin B₁₂ deficiency may also cause neurological symptoms such as numbness, tingling, poor balance, and memory problems. Laboratory findings include increased mean corpuscular volume (MCV), decreased serum Vitamin B₁₂ or folate levels, and hypersegmented neutrophils. Treatment consists of replacing the deficient vitamin and addressing the underlying cause.

4. Aplastic Anemia

Aplastic anemia is a rare but serious disorder in which the bone marrow fails to produce sufficient blood cells, including red blood cells, white blood cells, and platelets. Causes include certain medications, radiation exposure, toxic chemicals, viral infections, and autoimmune disorders. Patients develop pancytopenia, leading to fatigue, frequent infections, easy bruising, and excessive bleeding. Blood tests show low counts of all blood cells, while bone marrow examination reveals hypocellular marrow with reduced stem cells. Treatment may include blood transfusions, immunosuppressive therapy, antibiotics, and bone marrow transplantation, which offers the best chance of long-term cure in suitable patients.

5. Hemolytic Anemia

Hemolytic anemia occurs when red blood cells are destroyed faster than the bone marrow can replace them. The destruction may be inherited, such as sickle cell disease, or acquired due to autoimmune diseases, infections, drugs, or toxins. Symptoms include fatigue, pallor, jaundice, dark-colored urine, enlarged spleen (splenomegaly), and rapid heartbeat. Laboratory findings show increased reticulocyte count, elevated lactate dehydrogenase (LDH), increased indirect bilirubin, and decreased haptoglobin levels. Treatment depends on the cause and may include corticosteroids, immunosuppressants, blood transfusions, folic acid supplements, or removal of the spleen in selected cases.

6. Sickle Cell Anemia

Sickle Cell Anemia is an inherited autosomal recessive blood disorder caused by a mutation in the HBB gene on chromosome 11. This mutation produces abnormal hemoglobin called Hemoglobin S (HbS). Under low oxygen conditions, HbS polymerizes, causing red blood cells to become rigid and sickle-shaped. These abnormal cells break down easily, causing hemolytic anemia, and block small blood vessels, leading to painful vaso-occlusive crises. Patients experience anemia, pain episodes, jaundice, recurrent infections, delayed growth, and organ damage. Management includes hydroxyurea, blood transfusions, folic acid, antibiotics, and bone marrow transplantation in selected cases.

7. Thalassemia

Thalassemia is an inherited blood disorder caused by defective production of alpha or beta globin chains of hemoglobin. Reduced hemoglobin synthesis leads to microcytic, hypochromic anemia. Patients may develop severe anemia, fatigue, poor growth, enlarged spleen, facial bone deformities, and delayed puberty in severe forms. Laboratory tests reveal target cells on peripheral smear and increased HbA₂ or HbF, especially in beta-thalassemia. Mild cases may require little treatment, while severe forms need regular blood transfusions, iron chelation therapy to prevent iron overload, and bone marrow transplantation. Genetic counseling is important to reduce disease transmission.

8. RBC Size Guide

Red blood cells are classified according to their size using the Mean Corpuscular Volume (MCV). Microcytic anemia has an MCV of less than 80 fL and is commonly seen in iron deficiency anemia and thalassemia. Normocytic anemia has an MCV between 80–100 fL and occurs in aplastic anemia, hemolytic anemia, and acute blood loss. Macrocytic anemia has an MCV greater than 100 fL and is typically caused by Vitamin B₁₂ or folate deficiency. Measuring MCV helps doctors classify anemia, identify its cause, and choose appropriate investigations and treatment.

9. High-Yield Points

For Biology, remember that microcytic anemia includes iron deficiency anemia and thalassemia. Macrocytic anemia is mainly caused by Vitamin B₁₂ or folate deficiency, while normocytic anemia includes aplastic anemia, hemolytic anemia, and acute blood loss. Iron deficiency anemia is the most common anemia worldwide. Hemoglobin is the oxygen-carrying protein found inside red blood cells. Measuring MCV helps classify anemia into microcytic, normocytic, or macrocytic types. Understanding these classifications is essential for diagnosis and frequently appears in and other medical entrance examinations.

10. Normal Hemoglobin Level

Hemoglobin is the protein inside red blood cells responsible for transporting oxygen throughout the body. Normal hemoglobin levels differ between males and females. In adult males, the normal range is approximately 13.5–17.5 g/dL, while in adult females, it ranges from 12–15.5 g/dL. Hemoglobin levels below these values indicate anemia, whereas unusually high levels may occur in dehydration or certain blood disorders. Measuring hemoglobin is one of the simplest and most important blood tests for diagnosing anemia. Maintaining normal hemoglobin levels is essential for adequate oxygen delivery and overall health.

11. Remember: Anemia

An easy way to remember anemia is: "Low Hemoglobin = Low Oxygen = Low Energy." When the number of red blood cells or hemoglobin decreases, tissues receive less oxygen, leading to fatigue, weakness, pale skin, dizziness, and breathlessness. Different types of anemia have different causes, but all reduce oxygen transport. Early diagnosis using blood tests such as complete blood count (CBC), hemoglobin estimation, and red blood cell indices helps identify the underlying cause. Appropriate treatment, including nutritional supplementation, medications, blood transfusion, or bone marrow therapy, restores normal oxygen delivery and improves quality of life.

12. Sickle Cell Anemia – Definition

Sickle Cell Anemia is an inherited autosomal recessive disorder caused by abnormal hemoglobin called Hemoglobin S (HbS). The disease results from a mutation in the β-globin (HBB) gene, causing red blood cells to become sickle or crescent-shaped under low oxygen conditions. These sickled cells are fragile and break down easily, causing hemolytic anemia, while also blocking small blood vessels, leading to painful crises and organ damage. The disorder commonly affects people of African, Mediterranean, Middle Eastern, and Indian ancestry. Early diagnosis and lifelong medical care significantly improve patient survival and quality of life.

13. Cause of Sickle Cell Anemia

Sickle cell anemia is caused by a point mutation in the HBB gene located on chromosome 11. This mutation changes the genetic code from GAG to GTG, resulting in the replacement of glutamic acid with valine at the sixth position of the β-globin chain. The altered hemoglobin produced is called Hemoglobin S (HbS). Under low oxygen conditions, HbS molecules stick together and form long polymers, causing red blood cells to become rigid and sickle-shaped. The disease follows an autosomal recessive inheritance pattern, meaning both parents must pass on the abnormal gene.

14. Mutation in Sickle Cell Anemia

The mutation responsible for sickle cell anemia is a single nucleotide substitution in the β-globin gene. Normally, the sixth amino acid in the β-globin chain is glutamic acid, encoded by the DNA sequence GAG. In sickle cell disease, this sequence changes to GTG, replacing glutamic acid with valine. This single amino acid substitution changes the physical properties of hemoglobin, producing abnormal Hemoglobin S (HbS). Under low oxygen tension, HbS polymerizes into long fibers, causing red blood cells to become sickle-shaped, fragile, and prone to blocking blood vessels.

15. Inheritance Pattern

Sickle cell anemia follows an autosomal recessive inheritance pattern. A person must inherit one abnormal HbS gene from each parent to develop the disease. Individuals with one normal gene (HbA) and one HbS gene are carriers (sickle cell trait) and usually remain healthy. When both parents are carriers, each pregnancy has a 25% chance of producing a normal child, a 50% chance of producing a carrier, and a 25% chance of producing a child with sickle cell anemia. Genetic counseling helps families understand inheritance risks and make informed reproductive decisions.

16. Pathophysiology of Sickle Cell Anemia

In low oxygen conditions, Hemoglobin S (HbS) molecules polymerize into long rigid fibers inside red blood cells. This process changes the normal flexible biconcave cells into rigid, sickle-shaped cells. These abnormal cells are fragile and undergo hemolysis, leading to chronic anemia. They also become trapped in small blood vessels, causing vaso-occlusion, tissue ischemia, severe pain, and organ damage. Repeated episodes result in chronic complications affecting the spleen, kidneys, lungs, bones, and brain. The combination of hemolysis and vascular blockage is responsible for the characteristic symptoms and complications of sickle cell anemia.

17. Clinical Features

Patients with sickle cell anemia commonly experience chronic anemia, causing fatigue, weakness, pallor, and shortness of breath. Recurrent pain crises occur due to blockage of small blood vessels, especially in the bones, chest, abdomen, and joints. Other symptoms include jaundice, swelling of the hands and feet (particularly in children), delayed growth, recurrent infections due to splenic dysfunction, and enlarged spleen during early childhood. Severe complications may affect the brain, lungs, kidneys, and eyes. Symptoms vary among individuals but often worsen during dehydration, infection, cold exposure, or low oxygen levels.

18. Diagnosis of Sickle Cell Anemia

Diagnosis begins with a Complete Blood Count (CBC), showing low hemoglobin levels and anemia. A peripheral blood smear demonstrates characteristic sickle-shaped red blood cells and target cells. The gold standard test is Hemoglobin Electrophoresis, which identifies abnormal Hemoglobin S (HbS) and distinguishes it from normal hemoglobin (HbA). Genetic testing confirms mutations in the HBB gene and is useful for prenatal diagnosis and family screening. Early diagnosis through newborn screening programs allows prompt treatment, reducing complications and improving long-term survival. Laboratory evaluation is essential for accurate diagnosis and disease monitoring.

19. Complications of Sickle Cell Anemia

Sickle cell anemia can cause many serious complications due to repeated vaso-occlusion and hemolysis. Patients may develop stroke, acute chest syndrome, splenic sequestration, functional asplenia, leg ulcers, gallstones, kidney disease, and retinopathy affecting vision. Chronic anemia and repeated blood vessel blockage gradually damage multiple organs. Recurrent infections are common because the spleen loses its normal function. Without proper treatment, these complications significantly reduce life expectancy. Regular medical follow-up, vaccination, infection prevention, and early treatment help reduce complications and improve the quality and length of life.

20. Treatment of Sickle Cell Anemia

Treatment aims to reduce pain, prevent complications, and improve survival. Hydroxyurea increases fetal hemoglobin (HbF), reducing sickling and painful crises. Pain episodes are managed with analgesics and adequate hydration. Blood transfusions are used in severe anemia or complications such as stroke. Folic acid supplements support red blood cell production, while antibiotics and vaccinations help prevent infections. In selected patients, bone marrow (stem cell) transplantation offers a potential cure. Lifestyle measures include avoiding dehydration, maintaining adequate oxygenation, and receiving regular medical care. Genetic counseling is recommended for affected families.

21. Main Points

For Biology, remember that sickle cell anemia is an autosomal recessive disorder caused by a mutation in the β-globin (HBB) gene on chromosome 11. The mutation changes GAG to GTG, replacing glutamic acid with valine, producing Hemoglobin S (HbS). Red blood cells become sickle-shaped under low oxygen conditions, leading to hemolytic anemia and vaso-occlusion. Hb electrophoresis is the gold standard diagnostic test. Individuals with one HbS gene are carriers and generally remain healthy. This disease is common in Africa, the Mediterranean region, the Middle East, and parts of India.

22. High-Yield Facts

Individuals with HbA/HbS are heterozygous carriers and usually have no severe symptoms, whereas individuals with HbS/HbS develop sickle cell anemia. Carriers have partial protection against Plasmodium falciparum malaria, an example of balanced polymorphism, explaining why the HbS gene remains common in malaria-endemic regions. Hemoglobin electrophoresis confirms the diagnosis by detecting HbS. Under low oxygen conditions, HbS polymerizes, causing red blood cells to sickle. Hydroxyurea therapy increases fetal hemoglobin (HbF), reducing sickling episodes. These concepts are frequently tested in and other medical entrance examinations.

23. Difference Between Normal HbA and Abnormal HbS

Normal Hemoglobin (HbA) contains glutamic acid at the sixth position of the β-globin chain and remains soluble, allowing red blood cells to maintain their normal biconcave shape and transport oxygen efficiently. Abnormal Hemoglobin (HbS) contains valine instead of glutamic acid due to a point mutation. Under low oxygen conditions, HbS polymerizes, making red blood cells rigid and sickle-shaped. These abnormal cells have reduced flexibility, impaired oxygen transport, and are easily destroyed, leading to hemolytic anemia. The structural difference between HbA and HbS is responsible for all major features of sickle cell disease.

24. RBC Morphology

Normal red blood cells are biconcave discs, which are flexible and easily pass through small blood vessels while efficiently transporting oxygen. In sickle cell anemia, red blood cells become crescent or sickle-shaped when oxygen levels fall. These cells are rigid, fragile, and less deformable, making them prone to blockage of small blood vessels and premature destruction. Repeated sickling damages the cell membrane, causing chronic hemolysis and anemia. The characteristic sickle-shaped red blood cells seen on a peripheral blood smear are an important diagnostic feature and help differentiate sickle cell anemia from other blood disorders.